| Identification | Back Directory | [Name]
4,6-Pyrimidinediamine, N4-cyclohexyl-N6-(4-methoxyphenyl)- | [CAS]
1313491-22-3 | [Synonyms]
VUT-MK142
N4-Cyclohexyl-N6-(4-methoxyphenyl)pyrimidine-4,6-diamine
4,6-Pyrimidinediamine, N4-cyclohexyl-N6-(4-methoxyphenyl)-
Inhibitor,repair,VUT-MK142,mesoderm,VUT-MK-142,cardiac,cardiomyocyte,inhibit,VUTMK142,VUT MK142 | [Molecular Formula]
C17H22N4O | [MDL Number]
MFCD32878239 | [MOL File]
1313491-22-3.mol | [Molecular Weight]
298.38 |
| Chemical Properties | Back Directory | [Boiling point ]
499.9±40.0 °C(Predicted) | [density ]
1.203±0.06 g/cm3(Predicted) | [form ]
Solid | [pka]
5.71±0.10(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
VUT-MK142 is a potent new cardiomyogenic synthetic agent promoting the differentiation of pre-cardiac mesoderm into cardiomyocytes, which may be useful to differentiate stem cells into cardiomyocytes for cardiac repair[1]. | [References]
[1] Moumita Koley, et al. VUT-MK142 : a new cardiomyogenic small molecule promoting the differentiation of pre-cardiac mesoderm into cardiomyocytes. Medchemcomm. 2013 Aug 1;4(8):1189-1195. DOI:10.1039/C3MD00101F |
|
| Company Name: |
Bide Pharmatech Ltd.
|
| Telephone: |
400-1647117 13681763483 |
| Website: |
https://www.bidepharm.com/ |
|